Skip to content

Clinical trials

Phase 2 Carcinoma, Non-Small-Cell Lung trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 2 Country / region: Mexico Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20081
20091
20111
20121
20131
20151
20161
20182
20211
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Instituto Nacional de Cancerologia de Mexico3
AstraZeneca1
Bristol-Myers Squibb1
CytRx1
GlaxoSmithKline1
Hoffmann-La Roche1
Incyte Corporation1
Mirati Therapeutics Inc.1
National Institute of Cancerología1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung15
Lung Neoplasms3
Neoplasm Metastasis2
Adenocarcinoma of Lung1
Lung Diseases1
Lung Injury1
Radiation Fibrosis Syndrome1
Radiation Pneumonitis1
Respiratory Tract Neoplasms1
Thoracic Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.